文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

2005-2019年瑞士2岁儿童及时接种推荐麻疹疫苗方案的国家和地区差异

National and regional variations in timely adherence to recommended measles vaccination scheme in 2-years old in Switzerland, 2005-2019.
PubMed 文献 · Vaccine · 2022-04-15

研究利用2005-2019年瑞士全国疫苗接种覆盖率调查数据,评估2岁儿童麻疹含疫苗(MCV)及时接种情况,定义为在推荐年龄加30.4天宽限期内接种。2017-2019年MCV1及时接种率为81%(95%CI:79-82%),MCV2为82%(95%CI:81-83%)。2005-2019年MCV1和MCV2接种中位年龄分别为12.2-12.5月和18.3-22.0月,全国中位延迟分别为44天和38天;法语、意大利语和德语语区儿童接种较早。国籍、语言区域和调查期是与延迟延长相关的最强预测因素。

要点

  • 2017-2019年2岁儿童MCV1及时接种率为81%(95%CI:79-82%),MCV2为82%(95%CI:81-83%)。
  • 2005-2019年全国MCV1和MCV2接种中位延迟分别为44天和38天。
  • 法语、意大利语和德语语区儿童MCV1接种较早,10月龄前接种覆盖率范围分别为1.7-45.9%、1.2-35.3%和1.4-15.0%。

核心结论

  • 总体对建议的依从性随时间改善,MCV覆盖率多年来显著增加且存在语言区域差异;接种更早且延迟时间更短。

研究设计与样本

  • 研究使用2005-2019年瑞士全国疫苗接种覆盖率调查数据,纳入2岁儿童,评估MCV及时接种情况。

主要发现

  • 2017-2019年调查期,81%(95%CI:79-82%)的幼儿MCV1及时接种,82%(95%CI:81-83%)的幼儿MCV2及时接种。
  • 2005-2019年,全国MCV1接种中位年龄范围为12.2-12.5月,MCV2为18.3-22.0月,中位延迟分别为44天和38天。
  • 法语、意大利语和德语语区儿童在2005-2019年间MCV1接种较早,10月龄前接种覆盖率范围分别为1.7-45.9%、1.2-35.3%和1.4-15.0%。
  • 国籍、语言区域和调查期是与延迟延长相关的最强预测因素。

关键数值与推荐

  • 及时接种定义为在瑞士国家疫苗接种计划推荐年龄加30.4天宽限期内接种MCV1和MCV2。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although monitoring of vaccination program performance is usually evaluated by measurement of vaccine coverage, timely uptake is rarely part of this assessment. This study aims to examine the timeliness of the administration of a measles-containing-vaccine (MCV) for 2-year-old children between 2005 and 2019. METHODS: We used data from the Swiss National Vaccination Coverage Survey 2005-2019 for the study. We defined timely vaccinated as a vaccination administered within the recommended age specified in the Swiss National Vaccination Schedule, with an added tolerance period of 30.4 days for both MCV 1 and 2 doses. The median delay time was estimated by Kaplan-Meier survival curve and examined using log-rank test. A Cox hazard ratio was used to identify factors associated with delay. RESULTS: 81% (95% CI:79-82%) of toddlers were timely vaccinated for MCV1 and 82% (95% CI:81-83%) for MCV2 in survey period 2017-2019. Between 2005 and 2019, the median age of vaccinated children ranged between 12.2 and 12.5 and 18.3-22.0 months for MCV1 and MCV2 with median delay of 44 and 38 days, respectively, at the national level. Children in the French-, Italian- and German-speaking regions were vaccinated earlier between 2005 and 2019 for MCV1 (vaccination coverage range before 10 months of age: 1.7-45.9%, 1.2-35.3% and 1.4-15.0%, respectively). Nationality, linguistic regions, and survey periods were the strongest predictive factors related to prolonged delay time. CONCLUSION: Overall adherence to recommendations has improved over time, as MCV coverage has significantly increased over the years with differences across linguistic regions. Vaccinations were administered earlier and with shorter delay time.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Baroutsou V, Wymann M, Zens K, et al. National and regional variations in timely adherence to recommended measles vaccination scheme in 2-years old in Switzerland, 2005-2019. Vaccine. 2022. PMID: 35437190. doi:10.1016/j.vaccine.2022.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。